Bone and Soft Tissue Tumors About the Foot and Ankle

Murai, Naoki; Teniola, Oluwadamilola; Wang, Wei‐Lien; Amini, Behrang

doi:10.1016/j.rcl.2018.06.010

Cited by 16 publications

(5 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Computed tomography may be obtained for bone involvement and surgical planning. 19,25,37,38 Radiologic workup is usually followed by a fine-needle aspiration biopsy or Tru-Cut biopsy for a clinically reliable cytopathologic diagnosis in a high percentage of foot and ankle mass lesions. 14 Unplanned excisions without appropriate preoperative evaluation and biopsy are not uncommon.…”

Section: Introductionmentioning

confidence: 99%

Malignant Tumors of the Foot and Ankle

et al. 2022

View full text Add to dashboard Cite

Background: Surgical treatment is usually required for malignant foot and ankle tumors. In this study, we sought to review factors in treatment that may be associated with morbidity and mortality. Methods: All malignant foot and ankle tumors at our institution between April 1988 and April 2018 were retrospectively reviewed. The surgical modalities used and clinical outcomes of patients according to the anatomic location (Kirby zone) and clinical stage (Enneking system) of each tumor were described. Extent of surgical resection required, recurrence, and death rates were assessed. Results: Between April 1988 and April 2018, 80 patients with malignant tumors of the foot and ankle were treated at out institution. Mean age of patients was 42.6 (range, 3-89) years. Mean follow-up was 30.2 months (range, 24-120). Tumors were primary in 75 patients (94%) and metastatic from another organ in 5 patients (6%). Tumors originated from bone in 18 patients (22%) and from soft tissue in 63 patients (78%). Synovial sarcoma was the most common soft tissue tumor, and osteosarcoma was the most common osseous tumor. All patients had surgery to resect their tumor. Twenty-one (26%) had unplanned surgical procedures without initial biopsy at an outside institution prior to referral. Those patients were more likely to be treated with amputation or wide excison and free flap surgery ( P < .01). The recurrence rate was 50% for the unplanned surgery group and 22% for the planned surgery group. Mortality rate was 10% for the unplanned group and 6% for the planned group. The recurrence and mortality rate was higher in the unplanned group ( P = .03). Conclusion: Our study suggests that unplanned initial surgeries are associated with higher recurrence and mortality rates and reinforces the notion that these patients should be referred for treatment at a center with specialized expertise in tumor management. Level of Evidence: Level III, IV – retrospective case series.

show abstract

Section: Introductionmentioning

confidence: 99%

Malignant Tumors of the Foot and Ankle

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Intraosseous ganglion, giant cell tumour, osteoblastoma and other benign and malignant tumours of bone and soft tissues and metastases can appear in the ankle and should be considered in the differential diagnosis. 93 ‘Shoe rim pseudotumor’ is a soft tissue mass caused by prolonged local pressure and appears in snowboarders and figure skaters.…”

Section: Pain and Inflammation Of A Single Jointmentioning

confidence: 99%

Stop Searching under the Streetlight! A Primer and Practical Guide to the Diagnosis of Joint Pain and Inflammation

Krasin

Hemo

Doron

2022

MJR

View full text Add to dashboard Cite

It is impossible to achieve a diagnosis without a comprehensive list of possible diagnostic explanations for a certain symptom or syndrome. Joint complaints are very frequent in general practice, paediatrics, emergency medicine and naturally rheumatology and orthopaedics. The differential diagnosis of joint and surrounding tissue pain and inflammation is impressively challenging. Orthopaedic surgeons and rheumatologists deal with different aspects of this subject, while primary care physicians need to have a wider perspective that includes both orthopaedic and rheumatic disorders. The purpose of this paper is to provide a unified, comprehensive, clear and concise guide to this subject that will include both orthopaedic and rheumatic disorders and may serve the practitioner as basic reference for differential diagnosis. Short dictionary-style definitions would be given for each disorder in order to provide a ‘bird’s-eye view’, rather than an in-depth description of many diseases. Medical students, residents and primary care physicians are the primary target audience, but we believe that even the experienced orthopaedic surgeon or rheumatologist may benefit from a systematic and well-organised method.

show abstract

“…Superficial tumours, in contrast, are often detectable through palpation or may exhibit symptoms in the early stages of the disease. [14][15][16][17] The occurrence of benign musculoskeletal tumours is approximately 200 times more frequent than malignant counterparts. Specifically, tumours affecting the feet contribute to around 3% of all musculoskeletal tumour cases.…”

Section: Introductionmentioning

confidence: 99%

Tumours of the foot: A 10 years retrospective analysis

Ajit Singh,

Sandhu,

Tze Yong

et al. 2024

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

Introduction The foot is a complex structure composed of several tissues, each of which can be the origin of the proliferation and development of the tumour. Most lesions about the foot are reactive or inflammatory, but some are true neoplasms. Method This is a retrospective analysis of 4997 patient records treated in the Orthopaedic Oncology Unit of University Malaya Medical Centre, Malaysia, between 1 January 2010 to 31 December 2020. Demographic data of 195 patients with foot tumours were analysed out of 4997 neoplasm patients. Results There were 195 cases of foot tumours: 148 were benign, and 47 were malignant. 47 were bone tumours, 4 were metastases, and 144 were soft tissue tumours. Six patients succumbed to the disease, two cases of giant cell tumour (GCT) and one patient with synovial sarcoma had a recurrence. Treatment of foot tumours was wide resection in general. However, in metastasis cases, amputation was done. The majority of tumours were in the toes and dorsum of the foot. Soft tissue tumours of the foot occur in the elderly population in contrast to bone tumours, mainly in the second decade of life. The gender distribution was almost equal for foot tumours. Ganglion and Giant Cell Tumour of the bone are the commonest benign soft tissue and bone tumours. The most common malignant soft tissue and bone tumours are malignant melanoma and chondrosarcoma. The amputation rate is 5.64% the recurrence rate is 1.54%. Mortality rate is 3.08%. The MSTS score is 79%, and the TESS score is 76.23%. Conclusion Foot tumours are relatively rare, mostly originating from soft tissue and exhibiting a benign nature. Nonetheless, a noteworthy proportion—approximately a quarter of these tumours—demonstrate malignancy. The surgical interventions undertaken in managing these tumours and associated functional outcomes generally yield acceptable results.

show abstract

Bone and Soft Tissue Tumors About the Foot and Ankle

Cited by 16 publications

References 60 publications

Malignant Tumors of the Foot and Ankle

Malignant Tumors of the Foot and Ankle

Stop Searching under the Streetlight! A Primer and Practical Guide to the Diagnosis of Joint Pain and Inflammation

Tumours of the foot: A 10 years retrospective analysis

Contact Info

Product

Resources

About